The iShares Nasdaq Biotechnology Index ETF is on pace for its fourth-straight day of gains.
If you sold this ETF because you’re scared of Amazon, you made a big mistake, according to one equity strategist.
Todd Gordon, tradinganalysis.com, discusses the relationship between Amazon stock and the S&P Retail ETF and which stocks are coming back after taking a hit because of Amazon. The “Fast Money” traders weigh in.
CNBC's data partners at Kensho show that when the XLK, the tech ETF, is up more than seven percent in three months Micron is the best performer up more than four percent a month later
An unflattering profile piece this weekend in Barron's has generated some online discussion, and the portfolio manager himself published a response.
BlackRock, the world's largest asset-management firm, says its exchange-traded funds business had a record quarter.
Kevin O'Leary, chair Of O'Shares ETF Investments, lists stocks he expects to outperform the S&P into the end of the year.
Kevin O'leary, chair Of O'Shares ETF Investments discusses his market outlook for the financial sector and bank stocks.
Nick Fullerton from Fullerton Advisors says people can invest in the sports industry through an ETF that tracks companies sponsoring major sports leagues.
Among the biggest ETFs, the ones exposed to oil have performed the worst. Stacey Gilbert of Susquehanna and Matt Maley of Miller Tabak discuss with Brian Sullivan.